08/30/2024 7:04 AM | Hookipa Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2024 4:15 PM | Hookipa Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024 4:27 PM | Hookipa Pharma (Filer)
| Form 424B5 | |
08/02/2024 5:38 PM | Hookipa Pharma (Subject) Invus Global Management, LLC (Filed by)
| Form SC 13G/A | |
07/24/2024 3:17 PM | Hookipa Pharma (Issuer) Peters Malte (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/24/2024 3:18 PM | Coelho Mary Theresa (Reporting) Hookipa Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/24/2024 3:15 PM | Cassidy Sean A (Reporting) Hookipa Pharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
|
07/24/2024 3:16 PM | Cassidy Sean A (Reporting) Hookipa Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2024 6:00 AM | Hookipa Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/08/2024 5:51 PM | Artal International S.C.A. (Filed by) Hookipa Pharma (Subject)
| Form SC 13G | |
06/14/2024 5:52 PM | BAKER BROS. ADVISORS LP (Filed by) Hookipa Pharma (Subject)
| Form SC 13D | |
06/04/2024 3:15 PM | Hookipa Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/31/2024 4:25 PM | EcoR1 Capital, LLC (Filed by) Hookipa Pharma (Subject)
| Form SC 13G | |
05/23/2024 4:05 PM | Hookipa Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 6:03 AM | Hookipa Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 6:04 AM | Hookipa Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024 6:10 AM | Hookipa Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/17/2024 3:15 PM | Hookipa Pharma (Issuer) Necina Roman (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:15 PM | Hookipa Pharma (Issuer) Kandera Reinhard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:15 PM | Hookipa Pharma (Issuer) Winderlich Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:15 PM | Aldag Jorn (Reporting) Hookipa Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:15 PM | Hookipa Pharma (Issuer) Orlinger Klaus (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/11/2024 3:19 PM | Hookipa Pharma (Issuer) Winderlich Mark (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/22/2024 6:33 AM | Hookipa Pharma (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/22/2024 6:08 AM | Hookipa Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 4:47 PM | Hookipa Pharma (Subject)
| Form SC 13G/A | |
02/14/2024 4:47 PM | EcoR1 Capital, LLC (Filed by) EcoR1 Capital, LLC (Filed by) Hookipa Pharma (Subject)
| Form SC 13G/A | |
01/31/2024 3:30 PM | Hookipa Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/29/2024 7:12 AM | Hookipa Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 11:15 PM | Hookipa Pharma (Filer)
| Form EFFECT | |
12/22/2023 3:07 PM | GILEAD SCIENCES, INC. (Reporting) Hookipa Pharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
12/22/2023 6:33 AM | Hookipa Pharma (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
12/21/2023 6:06 AM | Hookipa Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/01/2023 3:46 PM | Hookipa Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 6:05 AM | Hookipa Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/09/2023 6:10 AM | Hookipa Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |